{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "42385-962",
      "generic_name": "Abacavir and Lamivudine",
      "labeler_name": "Laurus Labs Limited",
      "brand_name": "Abacavir and Lamivudine",
      "active_ingredients": [
        {
          "name": "ABACAVIR SULFATE",
          "strength": "600 mg/1"
        },
        {
          "name": "LAMIVUDINE",
          "strength": "300 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "42385-962-18",
          "description": "180 TABLET, FILM COATED in 1 BOTTLE (42385-962-18)",
          "marketing_start_date": "20220725",
          "sample": false
        },
        {
          "package_ndc": "42385-962-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (42385-962-30)",
          "marketing_start_date": "20220725",
          "sample": false
        },
        {
          "package_ndc": "42385-962-90",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (42385-962-90)",
          "marketing_start_date": "20220725",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "6ce5a446-f6a1-4efe-8a69-fd6ddf1a8ab2",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220725",
      "product_id": "42385-962_6ce5a446-f6a1-4efe-8a69-fd6ddf1a8ab2",
      "application_number": "ANDA216332",
      "brand_name_base": "Abacavir and Lamivudine",
      "pharm_class": [
        "Cytochrome P450 1A1 Inhibitors [MoA]",
        "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]",
        "Nucleoside Reverse Transcriptase Inhibitors [MoA]"
      ]
    }
  ]
}